vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Hudson Pacific Properties, Inc. (HPP). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $256.0M, roughly 1.9× Hudson Pacific Properties, Inc.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — -10.1% vs -109.4%, a 99.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 22.1%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (17.0% CAGR vs 9.4%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Hudson Pacific Properties is a real estate investment trust with 15.8 million square feet of office buildings, 1.5 million square feet of sound stages, and undeveloped rights for 3 million square feet of additional commercial property. Its properties are on the West Coast of the United States and Vancouver. It is organized in Maryland and headquartered in Los Angeles. It is the largest independent operator of sound stages in Los Angeles.

CLOV vs HPP — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.9× larger
CLOV
$487.7M
$256.0M
HPP
Growing faster (revenue YoY)
CLOV
CLOV
+22.6% gap
CLOV
44.7%
22.1%
HPP
Higher net margin
CLOV
CLOV
99.3% more per $
CLOV
-10.1%
-109.4%
HPP
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
17.0%
9.4%
HPP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLOV
CLOV
HPP
HPP
Revenue
$487.7M
$256.0M
Net Profit
$-49.3M
$-280.2M
Gross Margin
60.0%
Operating Margin
-10.1%
-109.8%
Net Margin
-10.1%
-109.4%
Revenue YoY
44.7%
22.1%
Net Profit YoY
-123.2%
-61.5%
EPS (diluted)
$-0.10
$-11.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
HPP
HPP
Q1 26
$487.7M
Q4 25
$487.7M
$256.0M
Q3 25
$496.6M
$186.6M
Q2 25
$477.6M
$190.0M
Q1 25
$462.3M
$198.5M
Q4 24
$337.0M
$209.7M
Q3 24
$331.0M
$200.4M
Q2 24
$356.3M
$218.0M
Net Profit
CLOV
CLOV
HPP
HPP
Q1 26
$-49.3M
Q4 25
$-49.3M
$-280.2M
Q3 25
$-24.4M
$-144.1M
Q2 25
$-10.6M
$-87.8M
Q1 25
$-1.3M
$-80.3M
Q4 24
$-22.1M
$-173.5M
Q3 24
$-9.2M
$-107.0M
Q2 24
$7.4M
$-47.6M
Gross Margin
CLOV
CLOV
HPP
HPP
Q1 26
Q4 25
60.0%
Q3 25
44.3%
Q2 25
43.1%
Q1 25
42.9%
Q4 24
44.7%
Q3 24
24.5%
42.7%
Q2 24
30.3%
48.0%
Operating Margin
CLOV
CLOV
HPP
HPP
Q1 26
-10.1%
Q4 25
-10.1%
-109.8%
Q3 25
-4.9%
-77.2%
Q2 25
-2.2%
-46.0%
Q1 25
-0.3%
-40.4%
Q4 24
-6.4%
-83.2%
Q3 24
-2.7%
-52.3%
Q2 24
2.0%
-21.6%
Net Margin
CLOV
CLOV
HPP
HPP
Q1 26
-10.1%
Q4 25
-10.1%
-109.4%
Q3 25
-4.9%
-77.2%
Q2 25
-2.2%
-46.2%
Q1 25
-0.3%
-40.5%
Q4 24
-6.6%
-82.7%
Q3 24
-2.8%
-53.4%
Q2 24
2.1%
-21.8%
EPS (diluted)
CLOV
CLOV
HPP
HPP
Q1 26
$-0.10
Q4 25
$-11.57
Q3 25
$-0.30
Q2 25
$-0.41
Q1 25
$-0.53
Q4 24
$-1.19
Q3 24
$-0.69
Q2 24
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
HPP
HPP
Cash + ST InvestmentsLiquidity on hand
$95.3M
$138.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$3.0B
Total Assets
$541.0M
$7.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
HPP
HPP
Q1 26
$95.3M
Q4 25
$78.3M
$138.4M
Q3 25
$190.4M
Q2 25
$236.0M
Q1 25
$86.5M
Q4 24
$194.5M
$63.3M
Q3 24
$288.0M
$90.7M
Q2 24
$254.8M
$78.5M
Stockholders' Equity
CLOV
CLOV
HPP
HPP
Q1 26
$308.7M
Q4 25
$308.7M
$3.0B
Q3 25
$340.9M
$3.2B
Q2 25
$344.2M
$3.4B
Q1 25
$336.1M
$2.8B
Q4 24
$341.1M
$2.9B
Q3 24
$342.2M
$3.0B
Q2 24
$324.9M
$3.1B
Total Assets
CLOV
CLOV
HPP
HPP
Q1 26
$541.0M
Q4 25
$541.0M
$7.3B
Q3 25
$559.7M
$7.8B
Q2 25
$575.0M
$8.1B
Q1 25
$583.7M
$8.0B
Q4 24
$580.7M
$8.1B
Q3 24
$653.0M
$8.3B
Q2 24
$674.2M
$8.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
HPP
HPP
Operating Cash FlowLast quarter
$0
$121.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
HPP
HPP
Q1 26
$0
Q4 25
$-66.9M
$121.0M
Q3 25
$12.1M
$33.2M
Q2 25
$5.4M
$-2.0M
Q1 25
$-16.3M
$30.5M
Q4 24
$34.8M
$164.7M
Q3 24
$50.0M
$63.7M
Q2 24
$44.8M
$35.6M
Free Cash Flow
CLOV
CLOV
HPP
HPP
Q1 26
Q4 25
$-69.0M
Q3 25
$11.4M
Q2 25
$4.8M
Q1 25
$-16.5M
Q4 24
$33.3M
Q3 24
$49.6M
Q2 24
$44.4M
FCF Margin
CLOV
CLOV
HPP
HPP
Q1 26
Q4 25
-14.1%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
-3.6%
Q4 24
9.9%
Q3 24
15.0%
Q2 24
12.5%
Capex Intensity
CLOV
CLOV
HPP
HPP
Q1 26
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
Cash Conversion
CLOV
CLOV
HPP
HPP
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

HPP
HPP

Core Office$217.1M85%
Studio Segment$21.8M9%
Ancillary Revenue$20.2M8%
Chargebacks$3.3M1%

Related Comparisons